"The computational systems biology community has made enormous progress in improving access to models," explains the EMBL-EBI's Nicolas Le Novère, lead author of the paper. "We've begun to share programming languages for encoding them (e.g. systems biology markup language, www.sbml.org) and to build public repositories so we can share them (e.g. www.ebi.ac.uk/biomodels). The current challenge is quality control: systems biologists won't use publicly available models if they can't search them properly, of if a model's reuse is hampered by a tiny mistake in the way that it's encoded. MIRIAM is an attempt to address these issues."
MIRIAM has two parts: (1) a set of checks that match a model to its description ('reference correspondence', often a publication in a scientific journal), and (2) a set of 'annotation schemes'. The first of these documents the model's provenance: who created it, whether it's been modified, and a stable link to its full description; the second scheme links the components of the model to relevant bioinformatics resources: for example, a model of alcohol metabolism in the liver would be annotated with links to the protein databases for all the enzymes involved in this pathway, and database links to all the relevant metabolites. The aim of these annotation schemes is to make it easier for researchers to search models on the basis of their components, to contact the creators of the model if they need more information, and to track the history of a model if it has been modified.
MIRIAM's creators include representatives of four major repositories for models (BioModels Database, CellML Model Repository, DOQCS and SigPath), all of which are now in the process of making the models in their repositories MIRIAM compliant. "By adopting MIRIAM as a voluntary code of conduct, we will be able to provide our users with a reasonable level of quality assurance, so they'll be able to get on with the business of generating and testing new hypotheses instead of recoding someone else's old hypothesis," continues Le Novère. "We also hope that journal editors will adopt MIRIAM as a quality control measure for papers that describe models. This approach has worked very well for other fields - for example the microarray community, by enabling authors, publishers and data providers to work together to improve access to meaningful biological information."
Source Article: N. Le Novère et al. Minimum information requested in the annotation of biochemical models (MIRIAM). Nat. Biotechnol., 6 December 2005
Press Contact: Cath Brooksbank PhD, EMBL-EBI Scientific Outreach Officer, Hinxton, Cambridge Tel: +44 (0)1223 492525, www.ebi.ac.uk, cath@ebi.ac.uk
About EMBL: The European Molecular Biology Laboratory is a basic research institute funded by public research monies from 18 member states. Research at EMBL is conducted by approximately 80 independent groups covering the spectrum of molecular biology. The Laboratory has five units: the main Laboratory in Heidelberg, and Outstations in Hinxton (the European Bioinformatics Institute), Grenoble, Hamburg, and Monterotondo near Rome. The cornerstones of EMBL's mission are: to perform basic research in molecular biology; to train scientists, students and visitors at all levels; to offer vital services to scientists in the member states; to develop new instruments and methods in the life sciences and to actively engage in technology transfer activities. EMBL's international PhD Programme has a student body of about 170. The Laboratory also sponsors an active Science and Society programme. Visitors from the press and public are welcome.
About EBI: The European Bioinformatics Institute (EBI) is part of the European Molecular Biology Laboratory (EMBL) and is located on the Wellcome Trust Genome Campus in Hinxton near Cambridge (UK). The EBI grew out of EMBL's pioneering work in providing public biological databases to the research community. It hosts some of the world's most important collections of biological data, including DNA sequences (EMBL-Bank), protein sequences (UniProt), animal genomes (Ensembl), three-dimensional structures (the Macromolecular Structure Database), data from microarray experiments (ArrayExpress), protein-protein interactions (IntAct) and pathway information (Reactome). The EBI hosts several research groups and its scientists continually develop new tools for the biocomputing community.
Policy regarding use: EMBL press releases may be freely reprinted and distributed via print and electronic media. Text, photographs & graphics are copyrighted by EMBL. They may be freely reprinted and distributed in conjunction with this news story, provided that proper attribution to authors, photographers and designers is made. High-resolution copies of the images can be downloaded from the EMBL web site: www.embl.org
Journal
Nature Biotechnology